Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

View source ↗

Summary

A National Institute of Allergy and Infectious Diseases trial update describes establishing fibroblast-derived cell lines from skin biopsies of patients with pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Immunodeficiency, DOCK8 | Status: ENROLLING_BY_INVITATION